| 1 | Development of A Radiomic Model for MGMT Promoter Methylation Detection in Glioblastoma Using Conventional MRI | 4.4 | 16 | Citations (PDF) |
| 2 | Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps | 2.3 | 4 | Citations (PDF) |
| 3 | Intraoperative in vivo confocal endomicroscopy of the glioma margin: performance assessment of image interpretation by neurosurgeon users | 2.6 | 5 | Citations (PDF) |
| 4 | The Role of Amide Proton Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor Grading, Molecular Profile and Survival in Different Tumor Components | 3.8 | 6 | Citations (PDF) |
| 5 | Fotemustine in recurrent high‑grade glioma: MRI neuro‑radiological findings | 1.9 | 2 | Citations (PDF) |
| 6 | P19.03.A CHARACTERIZATION OF THE IMMUNE MICROENVIRONMENT IN ATYPICAL MENINGIOMAS | 1.0 | 0 | Citations (PDF) |
| 7 | LZTR1
Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL | 25.1 | 19 | Citations (PDF) |
| 8 | Are Thalamic Intrinsic Lesions Operable? No-Man’s Land Revisited by the Analysis of a Large Retrospective, Mono-Institutional, Cohort | 3.8 | 6 | Citations (PDF) |
| 9 | Towards an Established Intraoperative Oncological Favorable Tool: Results of Fluorescein-Guided Resection from a Monocentric, Prospective Series of 93 Primary Glioblastoma Patients | 2.5 | 9 | Citations (PDF) |
| 10 | Case 310: Posterior Epidural Migration of a Lumbar Disk Herniation | 8.7 | 5 | Citations (PDF) |
| 11 | Distinct challenge: the case report of disseminated adult atypical choroid plexus papilloma | 1.7 | 1 | Citations (PDF) |
| 12 | Case report: Multiple brain intravascular papillary endothelial hyperplasia: incidence, diagnostic challenges, and management approach | 2.3 | 1 | Citations (PDF) |
| 13 | Cognitive and Behavioral Outcome of Pediatric Low-Grade Central Nervous System Tumors Treated Only with Surgery: A Single Center Experience | 2.8 | 1 | Citations (PDF) |
| 14 | P20.10.B CHARACTERIZATION OF NEW PROGNOSTIC MARKERS IN A COHORT OF ADULT SPINAL EPENDYMOMAS | 1.0 | 0 | Citations (PDF) |
| 15 | HGG-09. MicroRNAs expression profile in Meningioma 1 (MN1) gene altered astroblastoma | 1.0 | 0 | Citations (PDF) |
| 16 | How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment | 2.5 | 4 | Citations (PDF) |
| 17 | P11.68.A Hemangiopericytoma, case series and clinic-pathological analysis | 1.0 | 1 | Citations (PDF) |
| 18 | Interhemispheric Pediatric Meningioma, YAP1 Fusion-Positive | 2.8 | 4 | Citations (PDF) |
| 19 | Confocal laser imaging in neurosurgery: A comprehensive review of sodium fluorescein-based CONVIVO preclinical and clinical applications | 2.6 | 26 | Citations (PDF) |
| 20 | Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-up | 1.0 | 38 | Citations (PDF) |
| 21 | Confocal Laser Microscopy in Neurosurgery: State of the Art of Actual Clinical Applications | 2.5 | 23 | Citations (PDF) |
| 22 | Loss of H3K27me3 in meningiomas | 1.0 | 70 | Citations (PDF) |
| 23 | ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma | 6.3 | 27 | Citations (PDF) |
| 24 | Long term follow up in 183 high grade meningioma: A single institutional experience | 1.4 | 9 | Citations (PDF) |
| 25 | P14.57 WHO grade II and III meningioma: a large mono-institutional retrospective series | 1.0 | 0 | Citations (PDF) |
| 26 | P14.74 Grade II and III pleomorfic xanthoastrocitoma: a monocentric, retrospective analysis | 1.0 | 0 | Citations (PDF) |
| 27 | Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas | 3.5 | 26 | Citations (PDF) |
| 28 | mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma | 5.4 | 6 | Citations (PDF) |
| 29 | LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response | 12.5 | 46 | Citations (PDF) |
| 30 | Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches | 3.8 | 10 | Citations (PDF) |
| 31 | Sleeve-Shaped Neurothekeoma of the Ulnar Nerve: A Unique Case of a Still Unclear Pathological Entity | 1.3 | 1 | Citations (PDF) |
| 32 | CTIM-24. AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-α2, ARE WELL TOLERATED & RAPIDLY ENGRAFT IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (TEM-GBM_001 STUDY) | 1.0 | 1 | Citations (PDF) |
| 33 | Ex Vivo Fluorescein-Assisted Confocal Laser Endomicroscopy (CONVIVO® System) in Patients With Glioblastoma: Results From a Prospective Study | 2.6 | 41 | Citations (PDF) |
| 34 | Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series | 1.7 | 3 | Citations (PDF) |
| 35 | Peri-operative prognostic factors for primary skull base chordomas: results from a single-center cohort. | 1.5 | 7 | Citations (PDF) |
| 36 | High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient | 4.6 | 30 | Citations (PDF) |
| 37 | P05.02 A phase I/IIa dose escalation study evaluating the safety and efficacy of autologous CD34+ enriched hematopoietic progenitor cells genetically modified for human interferon-α2 in patients with GBM and an unmethylated MGMT promoter (TEM-GBM-001) | 1.0 | 0 | Citations (PDF) |
| 38 | Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy | 0.9 | 23 | Citations (PDF) |
| 39 | P09.03 Array-CGH analysis in meningiomas adds further information of biological behavior | 1.0 | 0 | Citations (PDF) |
| 40 | B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres | 9.7 | 162 | Citations (PDF) |
| 41 | Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients | 4.4 | 12 | Citations (PDF) |
| 42 | DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management | 1.0 | 262 | Citations (PDF) |
| 43 | Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood | 2.5 | 16 | Citations (PDF) |
| 44 | Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy | 11.0 | 32 | Citations (PDF) |
| 45 | The β- radio-guided surgery: Method to estimate the minimum injectable activity from ex-vivo test | 1.6 | 14 | Citations (PDF) |
| 46 | 5-ALA Fluorescence in Case of Brain Abscess by Aggregatibacter Mimicking Glioblastoma | 1.5 | 11 | Citations (PDF) |
| 47 | Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA | 9.1 | 59 | Citations (PDF) |
| 48 | ATIM-36. TEM-GBM-001 STUDY: AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-α2 & ADMINISTERED TO PATIENTS WITH GLIOBLASTOMA & AN UNMETHYLATED MGMT PROMOTER | 1.0 | 0 | Citations (PDF) |
| 49 | P14.64 Primary Central Nervous System Lymphoma (PCNSL) with HD- MTX based chemotherapy: tolerability and results | 1.0 | 0 | Citations (PDF) |
| 50 | Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma | 4.3 | 37 | Citations (PDF) |
| 51 | Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology | 3.5 | 68 | Citations (PDF) |
| 52 | In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting | 1.7 | 17 | Citations (PDF) |
| 53 | Microglia immunophenotyping in gliomas | 1.9 | 40 | Citations (PDF) |
| 54 | Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy | 12.5 | 125 | Citations (PDF) |
| 55 | Unique combination of myxopapillary ependymoma and conus lipoma with subcutaneous extension in an 11-month-old child | 0.9 | 2 | Citations (PDF) |
| 56 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsCell, 2018, 173, 400-416.e11 | 33.6 | 3,383 | Citations (PDF) |
| 57 | Comprehensive Characterization of Cancer Driver Genes and MutationsCell, 2018, 173, 371-385.e18 | 33.6 | 2,131 | Citations (PDF) |
| 58 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerCell, 2018, 173, 291-304.e6 | 33.6 | 2,413 | Citations (PDF) |
| 59 | A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient SamplesCell, 2018, 173, 386-399.e12 | 33.6 | 297 | Citations (PDF) |
| 60 | Perspective on Oncogenic Processes at the End of the Beginning of Cancer GenomicsCell, 2018, 173, 305-320.e10 | 33.6 | 375 | Citations (PDF) |
| 61 | Machine Learning Identifies Stemness Features Associated with Oncogenic DedifferentiationCell, 2018, 173, 338-354.e15 | 33.6 | 2,033 | Citations (PDF) |
| 62 | Oncogenic Signaling Pathways in The Cancer Genome AtlasCell, 2018, 173, 321-337.e10 | 33.6 | 2,971 | Citations (PDF) |
| 63 | Pathogenic Germline Variants in 10,389 Adult CancersCell, 2018, 173, 355-370.e14 | 33.6 | 820 | Citations (PDF) |
| 64 | Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types | 6.3 | 432 | Citations (PDF) |
| 65 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers | 6.3 | 583 | Citations (PDF) |
| 66 | Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas | 6.3 | 319 | Citations (PDF) |
| 67 | Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context | 6.3 | 240 | Citations (PDF) |
| 68 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma | 6.3 | 708 | Citations (PDF) |
| 69 | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images | 6.3 | 960 | Citations (PDF) |
| 70 | The Immune Landscape of Cancer | 22.6 | 5,116 | Citations (PDF) |
| 71 | Extensive and systematic rewiring of histone post-translational modifications in cancer model systems | 15.5 | 41 | Citations (PDF) |
| 72 | Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas | 6.3 | 148 | Citations (PDF) |
| 73 | Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types | 6.3 | 110 | Citations (PDF) |
| 74 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas | 6.3 | 1,060 | Citations (PDF) |
| 75 | Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers | 6.3 | 288 | Citations (PDF) |
| 76 | Systematic Analysis of Splice-Site-Creating Mutations in Cancer | 6.3 | 227 | Citations (PDF) |
| 77 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines | 5.8 | 825 | Citations (PDF) |
| 78 | Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas | 5.8 | 413 | Citations (PDF) |
| 79 | lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer | 33.0 | 457 | Citations (PDF) |
| 80 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy | 33.0 | 1,065 | Citations (PDF) |
| 81 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas | 33.0 | 519 | Citations (PDF) |
| 82 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers | 33.0 | 619 | Citations (PDF) |
| 83 | Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO) | 6.8 | 218 | Citations (PDF) |
| 84 | Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8
+
T cell activation in the presence of adjuvant temozolomide | 5.4 | 64 | Citations (PDF) |
| 85 | [OA109] Validation of a radio-guided surgery technique based on beta-radiation: Test on ex-vivo specimens | 1.6 | 0 | Citations (PDF) |
| 86 | P05.85 Mismatch repair system and immune-checkpoints profile in brain metastasis: study of 65 patients | 1.0 | 0 | Citations (PDF) |
| 87 | P05.45 Hydroxyurea (HU) or VAC (vincristine, adriamycin and cyclophosphamide) in a group of recurrent meningioma patients | 1.0 | 0 | Citations (PDF) |
| 88 | PATH-31. GIANT CELL GLIOBLASTOMAS: ANALYSIS OF MISMATCH-REPAIR (MMR) PROTEINS EXPRESSION, POLIMERASE ε (POLE) MUTATIONS AND THEIR ROLE IN TUMOR IMMUNORESPONSE | 1.0 | 1 | Citations (PDF) |
| 89 | P02.06 De-novo ceramide synthesis in skull base chordomas suggests a correlation with tumor proliferation | 1.0 | 0 | Citations (PDF) |
| 90 | A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily | 5.8 | 174 | Citations (PDF) |
| 91 | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer | 6.3 | 492 | Citations (PDF) |
| 92 | P01.150 hypermutations in glioblastoma are associated with increased response to immunotherapy | 1.0 | 0 | Citations (PDF) |
| 93 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients | 33.0 | 890 | Citations (PDF) |
| 94 | Mutations targeting the coagulation pathway are enriched in brain metastases | 3.4 | 11 | Citations (PDF) |
| 95 | P03.13 Molecular and clinical bio-markers in a series of 48 consecutive skull base chordoma patients | 1.0 | 0 | Citations (PDF) |
| 96 | P16.14 Treatment of thalamic glial lesions: surgery versus biopsy | 1.0 | 0 | Citations (PDF) |
| 97 | P03.19 AQP4 in brain metastasis: its role and cross talk with the brain microenvironment. | 1.0 | 1 | Citations (PDF) |
| 98 | Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis | 1.4 | 6 | Citations (PDF) |
| 99 | Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim–Chester disease | 3.4 | 18 | Citations (PDF) |
| 100 | HG-56HISTONE K27M MUTATION IN A SERIES OF CENTRALLY REVIEWED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): CONSISTENCY WITH MRI FEATURES | 1.0 | 0 | Citations (PDF) |
| 101 | HG-11BRAF V600E MUTATION IN PEDIATRIC ASTROBLASTOMAS | 1.0 | 0 | Citations (PDF) |
| 102 | MPTH-42. NEUROPATHOLOGICAL AND MOLECULAR CHARACTERIZATION OF LONG-TERM SURVIVAL GLIOBLASTOMAS (LS-GBM): A STUDY ON 52 CASES | 1.0 | 0 | Citations (PDF) |
| 103 | A case of medulloblastoma in adult patient affected by anaplastic oligoastrocytoma | 1.7 | 2 | Citations (PDF) |
| 104 | Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma | 1.0 | 131 | Citations (PDF) |
| 105 | First ex vivo validation of a radioguided surgery technique withβ-radiation. | 1.6 | 31 | Citations (PDF) |
| 106 | OS2.8 Survival gain and immune response in glioblastoma patients treated with dendritic cell immunotherapy before and during adjuvant temozolomide | 1.0 | 0 | Citations (PDF) |
| 107 | Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model | 11.3 | 102 | Citations (PDF) |
| 108 | MPTH-28STUDY OF THE ROLE OF IFI-16 EXPRESSION IN GLIOMAS | 1.0 | 0 | Citations (PDF) |
| 109 | Primary central nervous system angiosarcoma: A case report and literature review | 1.2 | 26 | Citations (PDF) |
| 110 | IMCT-06SURVIVAL GAIN AND IMMUNE RESPONSE IN GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY BEFORE AND DURING ADJUVANT TEMOZOLOMIDE | 1.0 | 0 | Citations (PDF) |
| 111 | Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas | 34.5 | 3,041 | Citations (PDF) |
| 112 | Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma | 5.0 | 117 | Citations (PDF) |
| 113 | Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival | 2.5 | 35 | Citations (PDF) |
| 114 | P17.10 * GEMISTOCYTIC ASTROCYTOMAS: MONO-INSTITUTIONAL EXPERIENCE | 1.0 | 0 | Citations (PDF) |
| 115 | ME-16 * IS AQUAPORIN4 (AQP4) INVOLVED IN ADULT HUMAN MEDULLOBLASTOMA DISSEMINATION OR IN A BENEFICIAL BARRIER FORMATION? | 1.0 | 1 | Citations (PDF) |
| 116 | O1.04 * ROLE OF AQUAPORIN4 IN HUMAN BRAIN METASTASES: STUDY OF 60 CASES | 1.0 | 1 | Citations (PDF) |
| 117 | O5.05 * FLUORESCEIN-GUIDED REMOVAL OF HIGH-GRADE GLIOMAS WITH A DEDICATED FILTER ON THE SURGICAL MICROSCOPE: PRELIMINARY RESULTS OF THE FLUOGLIO STUDY | 1.0 | 1 | Citations (PDF) |
| 118 | P06.14 * MALIGNANT TRANSFORMATION OF MENINGIOMA WITH METASTASES IN YOUNG WOMAN | 1.0 | 0 | Citations (PDF) |
| 119 | P17.71 * ROLE OF ATRX AND TERT EXPRESSION AS DIAGNOSTIC AND PROGNOSTIC FACTORS ON ANAPLASTIC GLIOMAS | 1.0 | 0 | Citations (PDF) |
| 120 | P03.08 * IMPROVED YIELD OF STEM-LIKE CELLS USING GLIOBLASTOMA SUSPENSIONS FROM CAVITRON ULTRASONIC SURGERY ASPIRATOR (CUSA) BAGS AS STARTING MATERIAL | 1.0 | 0 | Citations (PDF) |
| 121 | P02.03 * INCREASED COUNTS OF NK AND NKT CELLS ARE ASSOCIATED WITH PROLONGED SURVIVAL IN PRIMARY GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY IN COMBINATION WITH RADIO- AND CHEMO-THERAPY | 1.0 | 1 | Citations (PDF) |
| 122 | Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood | 2.5 | 67 | Citations (PDF) |
| 123 | Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010 | 1.0 | 80 | Citations (PDF) |
| 124 | O8.06 * ATRX AND TERT EXPRESSION IN RELAPSING LOW GRADE GLIOMA | 1.0 | 1 | Citations (PDF) |
| 125 | P12.05 * THE EVOLUTION TOWARDS MINIMALLY INVASIVE SURGERY IN CRANIOPHARYNGIOMAS AND SKULL BASE CHORDOMAS | 1.0 | 0 | Citations (PDF) |
| 126 | Histological variants of medulloblastoma are the most powerful clinical prognostic indicators | 1.3 | 44 | Citations (PDF) |
| 127 | Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor | 2.9 | 14 | Citations (PDF) |
| 128 | Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases | 1.5 | 139 | Citations (PDF) |
| 129 | The Somatic Genomic Landscape of Glioblastoma | 33.6 | 4,805 | Citations (PDF) |
| 130 | Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience | 1.7 | 14 | Citations (PDF) |
| 131 | Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres | 29.2 | 14 | Citations (PDF) |
| 132 | OMICS AND PROGNSTIC MARKERS | 1.0 | 1 | Citations (PDF) |
| 133 | The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates | 5.4 | 61 | Citations (PDF) |
| 134 | Preoperative Embolization of Carotid Chemodectoma: A Technical Challenge that can be Customized According to Angioarchitecture | 1.0 | 10 | Citations (PDF) |
| 135 | 109 Tyrosine Kinase Receptors as Functional Markers and Therapeutical Targets of Glioblastoma Stem Cells | 4.9 | 0 | Citations (PDF) |
| 136 | Multidrug resistance proteins expression in glioma patients with epilepsy | 2.5 | 31 | Citations (PDF) |
| 137 | Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma | 2.5 | 25 | Citations (PDF) |
| 138 | The
MET
Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype | 3.8 | 122 | Citations (PDF) |
| 139 | FABP4 is a candidate marker of cerebellar liponeurocytomas | 2.5 | 29 | Citations (PDF) |
| 140 | An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma | 2.3 | 33 | Citations (PDF) |
| 141 | Expression of the new CXCL12 receptor, CXCR7, in gliomas | 4.1 | 47 | Citations (PDF) |
| 142 | Spinal cord stimulation for recurrent painful neuromas of the foot | 1.7 | 6 | Citations (PDF) |
| 143 | Neuropathological diagnosis of brain tumours | 1.7 | 18 | Citations (PDF) |
| 144 | DNA Microarray Analysis Identifies CKS2 and LEPR as Potential Markers of Meningioma Recurrence | 3.4 | 27 | Citations (PDF) |
| 145 | Expression profile of frizzled receptors in human medulloblastomas | 2.5 | 14 | Citations (PDF) |
| 146 | Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience | 2.5 | 22 | Citations (PDF) |
| 147 | Expression of vascular endothelial growth factor receptor-1/-2 and nitric oxide in unruptured intracranial aneurysms | 1.7 | 10 | Citations (PDF) |
| 148 | CXCL12, CXCR4 and CXCR7 expression in brain metastases | 4.1 | 84 | Citations (PDF) |
| 149 | Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels | 2.5 | 63 | Citations (PDF) |
| 150 | Epilepsy in cerebral glioma: timing of appearance and histological correlations | 2.5 | 86 | Citations (PDF) |
| 151 | Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution | 6.5 | 183 | Citations (PDF) |
| 152 | Aquaporin-4 contributes to the resolution of peritumoural brain oedema in human glioblastoma multiforme after combined chemotherapy and radiotherapy | 4.9 | 53 | Citations (PDF) |
| 153 | Expression of cannabinoid receptors and neurotrophins in human gliomas | 1.7 | 40 | Citations (PDF) |
| 154 | Intracerebral haemorrhage in primary and metastatic brain tumours | 1.7 | 11 | Citations (PDF) |
| 155 | Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim-Chester disease | 1.7 | 17 | Citations (PDF) |
| 156 | Radiation‐induced glioblastoma in a medulloblastoma patient: A case report with molecular features | 1.2 | 20 | Citations (PDF) |
| 157 | Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma | 1.0 | 188 | Citations (PDF) |
| 158 | MUCINOUS LOW-GRADE ADENOCARCINOMA ARISING IN AN INTRACRANIAL ENTEROGENOUS CYST | 2.0 | 31 | Citations (PDF) |
| 159 | Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1 | 1.0 | 36 | Citations (PDF) |
| 160 | Nestin, PDGFR-β, CXCL12 and VEGF in gliomapatients: Different profiles of (Pro-Angiogenic) molecule expression are related with tumor grade and may provide prognostic information | 4.1 | 52 | Citations (PDF) |
| 161 | Loss of heterozygosity studies in extracranial metastatic meningiomas | 2.5 | 16 | Citations (PDF) |
| 162 | Meningitis following relapsing painful ophthalmoplegia in aspergillus sphenoidal sinusitis: a case report | 1.7 | 14 | Citations (PDF) |
| 163 | Reclassification of oligoastrocytomas by loss of heterozygosity studies | 4.3 | 53 | Citations (PDF) |
| 164 | Molecular markers of gliomas: a clinical approach | 1.5 | 10 | Citations (PDF) |
| 165 | Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas | 4.1 | 36 | Citations (PDF) |
| 166 | Production and post-surgical modification of VEGF, tPA and PAI-1 in patients with glioma | 4.1 | 11 | Citations (PDF) |
| 167 | Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience | 2.5 | 21 | Citations (PDF) |
| 168 | Anaplasia Is Rare and Does Not Influence Prognosis in Adult Medulloblastoma | 1.8 | 23 | Citations (PDF) |
| 169 | Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma | 2.5 | 197 | Citations (PDF) |
| 170 | CXCL12 Expression is Predictive of a Shorter Time to Tumor Progression in Low-Grade Glioma: A Single-Institution Study in 50 Patients | 2.5 | 57 | Citations (PDF) |
| 171 | hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines | 5.5 | 139 | Citations (PDF) |
| 172 | Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines | 6.5 | 103 | Citations (PDF) |
| 173 | Neuromyelitis Optica in a Child with Atypical Onset and Severe Outcome | 1.2 | 4 | Citations (PDF) |
| 174 | CXCL12 in Malignant Glial Tumors: A Possible Role in Angiogenesis and Cross-Talk between Endothelial and Tumoral Cells | 2.5 | 75 | Citations (PDF) |
| 175 | Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study | 1.5 | 100 | Citations (PDF) |
| 176 | Title is missing! | 29.2 | 69 | Citations (PDF) |
| 177 | Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types | 1.9 | 52 | Citations (PDF) |
| 178 | Title is missing! | 2.5 | 19 | Citations (PDF) |
| 179 | Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis | 4.3 | 58 | Citations (PDF) |
| 180 | Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas | 3.5 | 36 | Citations (PDF) |
| 181 | The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines | 6.5 | 81 | Citations (PDF) |
| 182 | Association of chromosome 10 losses and negative prognosis in oligoastrocytomas | 6.6 | 32 | Citations (PDF) |
| 183 | Modulation of Experimental Allergic Encephalomyelitis in Lewis Rats by Administration of a Peptide of Fas Ligand | 6.6 | 9 | Citations (PDF) |
| 184 | Utilizzo intraoperatorio delle immagini di spettroscopia RM nella chirurgia dei tumori cerebrali e correlazione con la neuropatologia | 0.0 | 0 | Citations (PDF) |
| 185 | Title is missing! | 2.5 | 14 | Citations (PDF) |
| 186 | Gene therapy of experimental brain tumors using neural progenitor cells | 33.0 | 461 | Citations (PDF) |
| 187 | Title is missing! | 2.5 | 9 | Citations (PDF) |
| 188 | Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells? | 2.3 | 22 | Citations (PDF) |
| 189 | Meningo-cortical calcifying angiomatosis and celiac disease | 1.4 | 10 | Citations (PDF) |
| 190 | Limited Efficacy of the HSV-TK/GCV System for Gene Therapy of Malignant Gliomas and Perspectives for the Combined Transduction of the Interleukin-4 Gene | 3.2 | 69 | Citations (PDF) |
| 191 | TOPOGRAPHY OF PHOSPHORYLATED TAU IMMUNOREACTIVITY IN ALZHEIMER DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY AND PICK DISEASE | 1.8 | 0 | Citations (PDF) |
| 192 | The “Bystander Effect”: Association of U-87 Cell Death with Ganciclovir-Mediated Apoptosis of Nearby Cells and Lack of Effect in Athymic Mice | 3.2 | 137 | Citations (PDF) |
| 193 | Intracranial dissemination of pituitary adenoma. Case report and review of the literature | 0.4 | 9 | Citations (PDF) |
| 194 | Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin | 1.0 | 0 | Citations (PDF) |
| 195 | Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin | 1.0 | 51 | Citations (PDF) |
| 196 | P53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomas | 1.2 | 11 | Citations (PDF) |
| 197 | Increasing complexity of the karyotype in 50 human gliomas | 1.2 | 52 | Citations (PDF) |
| 198 | Low frequency of NF1 gene mutations in malignant gliomas | 4.9 | 2 | Citations (PDF) |
| 199 | ßPP Participates in PrP-Amyloid Plaques of Gerstmann-Sträussler-Scheinker Disease, Indiana Kindred | 1.8 | 50 | Citations (PDF) |
| 200 | Gliomatosis cerebri. Report of a case with isolated amnesic disorders | 0.4 | 16 | Citations (PDF) |
| 201 | Proliferating cell nuclear antigen expression in central nervous system neoplasms | 1.5 | 104 | Citations (PDF) |
| 202 | Histologic prognostic factors in ependymoma | 0.9 | 145 | Citations (PDF) |
| 203 | CEREBRAL PREAMYLOID DEPOSITS AND CONGOPHILIC ANGIOPATHY IN AGED DOGS | 1.8 | 0 | Citations (PDF) |
| 204 | Cytochromec oxidase and coenzyme Q in neuromuscular diseases: a histochemical study | 9.1 | 8 | Citations (PDF) |
| 205 | Alzheimer patients and Down patients: Abnormal presynaptic terminals are related to cerebral preamyloid deposits | 1.9 | 55 | Citations (PDF) |
| 206 | Cerebral preamyloid deposits and congophilic angiopathy in aged dogs | 1.9 | 91 | Citations (PDF) |
| 207 | Free cytoplasmic Ca
++
at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients | 1.0 | 88 | Citations (PDF) |
